Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: Validation study on the European Association of Urology guidelines

BJU International

Volumn 107, Issue 10, 2011, Pages 1598-1604

  Sakano, Shigeru ^a   Matsuyama, Hideyasu ^a   Takai, Kimio ^b   Yoshihiro, Satoru ^c   Kamiryo, Yoriaki ^d   Shirataki, Satoshi ^e   Kaneda, Yoshitaka ^f   Hashimoto, Osamu ^g   Joko, Keiji ^h   Suga, Akinobu ⁱ   Yamamoto, Mitsutaka ^j   Hayashida, Shigeaki ^k   Baba, Yoshikazu ^l   Aoki, Akihiko ^m  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Konan St Hill Hospital   (Japan)

^c Saiseikai Shimonoseki General Hospital   (Japan)

^d Shimonoseki City Central Hospital   (Japan)

^e Department of Urology   (Japan)

^f YAMAGUCHI ROSAI HOSPITAL   (Japan)

^g Ogori Daiichi General Hospital   (Japan)

^h Saiseikai Yamaguchi General Hospital   (Japan)

ⁱ YAMAGUCHI RED CROSS HOSPITAL   (Japan)

^j Yamaguchi Grand Medical Center   (Japan)

^k Tokuyama Central Hospital   (Japan)

^l Shuto General Hospital   (Japan)

^m Masuda Red Cross Hospital   (Japan)

more..

Author keywords

carcinoma; recurrence; transitional cell; urinary bladder

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TRANSURETHRAL RESECTION; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; URINARY BLADDER NEOPLASMS;

EID: 79955425871     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09850.x     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 (Pubitemid 40372904)
2. Dyrskjot L, Zieger K, Real FX, et al,. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. Clin Cancer Res 2007; 13: 3545-51 (Pubitemid 46955114)
3. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al,. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-5; discussion 475-7
4. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J,. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008; 54: 303-14
5. Orsola A, Cecchini L, Morote J,. Re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-14. Eur Urol 2009; 55: e15-6; author reply e7-8
6. Oosterlinck W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C,. Guidelines on bladder cancer. Eur Urol 2002; 41: 105-12 (Pubitemid 35428874)
7. Matsuda T, Katanoda K,. Comparison of time trends in bladder cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. Jpn J Clin Oncol 2008; 38: 85-6
8. Marugame T, Kaneko S,. Comparison of bladder cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000). Jpn J Clin Oncol 2005; 35: 357-60 (Pubitemid 41444286)
9. UICC: International Union Against Cancer. TNM Classification of Malignant Tumours. Berlin: Springer-Verlag, 2002
10. Mostofi FK, Sorbin LH, Torloni H,. Histological Typing of Urinary Bladder Tumours. International Classification of Tumours, 19. Geneva: World Health Organization, 1973
11. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J,. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 73-8
12. Ali-El-Dein B, Sarhan O, Hinev A, Ibrahiem el HI, Nabeeh A, Ghoneim MA,. Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index. BJU Int 2003; 92: 393-9 (Pubitemid 37100517)
13. Hong SJ, Cho KS, Han M, et al,. Nomograms for prediction of disease recurrence in patients with primary Ta, T1 transitional cell carcinoma of the bladder. J Korean Med Sci 2008; 23: 428-33
14. Kikuchi E, Fujimoto H, Mizutani Y, et al,. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Int J Urol 2009; 16: 279-86
15. Matos T, Cufer T, Cervek J, Bornstnar S, Kragelj B, Zumer-Pregelj M,. Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach). Int J Radiat Oncol Biol Phys 2000; 46: 403-9 (Pubitemid 30067790)
16. Yang MH, Yen CC, Chen PM, et al,. Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan. Urology 2002; 59: 232-8; discussion 238-9
17. Fokdal L, Hoyer M, von der Maase H,. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Acta Oncol 2004; 43: 749-57 (Pubitemid 40066018)
18. Sengelov L, Kamby C, Schou G, von der Maase H,. Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract. Cancer 1994; 74: 123-33 (Pubitemid 24187620)
19. Underwood W III, Dunn RL, Williams C, Lee CT,. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg 2006; 202: 284-90 (Pubitemid 43112488)
20. Horvath A, Mostafid H,. Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer. BJU Int 2009; 103: 726-9
21. Sylvester RJ, Oosterlinck W, van der Meijden AP,. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004; 171: 2186-90, quiz 2435 (Pubitemid 38625431)
22. Pawinski A, Sylvester R, Kurth KH, et al. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol 1996; 156: 1934-40, discussion 1940-1
23. Sylvester RJ, van der MA, Lamm DL,. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002; 168: 1964-70